Literature DB >> 17499826

Cutaneous leishmaniasis in southern Sri Lanka.

U S Rajapaksa1, R L Ihalamulla, C Udagedera, N D Karunaweera.   

Abstract

Cutaneous leishmaniasis is an established disease in Sri Lanka. The majority of cases have been reported from the North-Central Province, with the southern parts of the country considered less affected. However, during 2004, when the services of a dermatologist were available, a considerable number of patients were referred from the Southern Province, which formed the basis for this study. The clinical pattern, detailed geographical distribution within the Southern Province and periodicity of the cases were studied over a period of 12 months. Of the 113 patients diagnosed, the highest number was within the 10-19 years age group. Most patients were from densely populated rural areas around Matara, a large town within this province. There was a notable increase in the number of cases presenting during February-March and August-September, which are periods following monsoonal rains. Exposed areas of the skin were commonly affected, with the majority of patients having single lesions. Females and males were equally affected. This is in contrast to our previous findings in the North-Central Province where the majority of patients were male soldiers with multiple lesions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17499826     DOI: 10.1016/j.trstmh.2006.05.013

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  15 in total

1.  Emergence of visceral leishmaniasis in Sri Lanka: a newly established health threat.

Authors:  H V Y D Siriwardana; P Karunanayake; L Goonerathne; N D Karunaweera
Journal:  Pathog Glob Health       Date:  2017-08-18       Impact factor: 2.894

2.  Use of a clinical tool for screening and diagnosis of cutaneous leishmaniasis in Sri Lanka.

Authors:  H V Y D Siriwardana; U Senarath; P H Chandrawansa; N D Karunaweera
Journal:  Pathog Glob Health       Date:  2015-07-16       Impact factor: 2.894

3.  Clinical and epidemiological characteristics of cutaneous leishmaniasis in Sri Lanka.

Authors:  Devika Iddawela; Sanura Malinda Pallegoda Vithana; Dhilma Atapattu; Lanka Wijekoon
Journal:  BMC Infect Dis       Date:  2018-03-06       Impact factor: 3.090

4.  Characterisation of cutaneous leishmaniasis in Matara district, southern Sri Lanka: evidence for case clustering.

Authors:  K K G D U L Kariyawasam; C S Edirisuriya; U Senerath; D Hensmen; H V Y D Siriwardana; N D Karunaweera
Journal:  Pathog Glob Health       Date:  2015-09-07       Impact factor: 2.894

5.  An epidemiological study of cutaneous leishmaniasis in Al-jabal Al-gharbi, Libya.

Authors:  Manal Z M Abdellatif; Khamis El-Mabrouk; Ashraf A Ewis
Journal:  Korean J Parasitol       Date:  2013-02-18       Impact factor: 1.341

6.  Role of remote sensing, geographical information system (GIS) and bioinformatics in kala-azar epidemiology.

Authors:  Gouri Sankar Bhunia; Manas Ranjan Dikhit; Shreekant Kesari; Ganesh Chandra Sahoo; Pradeep Das
Journal:  J Biomed Res       Date:  2011-11

7.  Leishmaniasis: Path toward elimination from the Indian subcontinent.

Authors:  Nadira D Karunaweera
Journal:  Trop Parasitol       Date:  2016 Jan-Jun

Review 8.  Leishmaniasis in Sri Lanka: spatial distribution and seasonal variations from 2009 to 2016.

Authors:  Lahiru Sandaruwan Galgamuwa; Samath D Dharmaratne; Devika Iddawela
Journal:  Parasit Vectors       Date:  2018-01-25       Impact factor: 3.876

9.  Clinico-Epidemiological Patterns of Cutaneous Leishmaniasis Patients Attending the Anuradhapura Teaching Hospital, Sri Lanka.

Authors:  Lahiru Sandaruwan Galgamuwa; Buthsiri Sumanasena; Lalani Yatawara; Susiji Wickramasinghe; Devika Iddawela
Journal:  Korean J Parasitol       Date:  2017-02-28       Impact factor: 1.341

10.  A case report of co-infection of Melioidosis and cutaneous Leishmaniasis.

Authors:  Isuru Chamika Indeewara Kahandawaarachchi; Gayani Samadara Premawansa; Wipula Warnasuriya; Malka Dassanayake; Enoka Corea
Journal:  BMC Infect Dis       Date:  2017-08-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.